Adherence to Stage-Specific Treatment Guidelines for Patients With Colon Cancer

Abstract

Significant variation exists in the treatment of colon cancer, particularly in treatment of high-risk stage II and stage III disease. The impact of nonadherence to guidelines on patient outcomes needs to be further elucidated.